Literature DB >> 16935921

Adalimumab-associated pulmonary fibrosis.

M T Huggett, R Armstrong.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16935921     DOI: 10.1093/rheumatology/kel220

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  8 in total

Review 1.  Anaesthesiological problems in patients with rheumatoid arthritis undergoing orthopaedic surgeries.

Authors:  Barbara Lisowska; Lidia Rutkowska-Sak; Pawel Maldyk; Renata Cwiek
Journal:  Clin Rheumatol       Date:  2008-01-18       Impact factor: 2.980

2.  Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register.

Authors:  W G Dixon; K L Hyrich; K D Watson; M Lunt; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2010-05-05       Impact factor: 19.103

3.  Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Robert P Baughman; Keith C Meyer; Ian Nathanson; Luis Angel; Sangeeta M Bhorade; Kevin M Chan; Daniel Culver; Christopher G Harrod; Mary S Hayney; Kristen B Highland; Andrew H Limper; Herbert Patrick; Charlie Strange; Timothy Whelan
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

4.  Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro/adipogenic progenitors.

Authors:  Dario R Lemos; Farshad Babaeijandaghi; Marcela Low; Chih-Kai Chang; Sunny T Lee; Daniela Fiore; Regan-Heng Zhang; Anuradha Natarajan; Sergei A Nedospasov; Fabio M V Rossi
Journal:  Nat Med       Date:  2015-06-08       Impact factor: 53.440

5.  Drug induced interstitial lung disease.

Authors:  Martin Schwaiblmair; Werner Behr; Thomas Haeckel; Bruno Märkl; Wolfgang Foerg; Thomas Berghaus
Journal:  Open Respir Med J       Date:  2012-07-27

6.  Adalimumab (Humira) induced acute lung injury.

Authors:  Ritesh Kohli; Karim Namek
Journal:  Am J Case Rep       Date:  2013-05-27

Review 7.  Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis.

Authors:  Shunsuke Mori
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-09-08

8.  Adalimumab-induced acute interstitial lung disease in a patient with rheumatoid arthritis.

Authors:  Olívia Meira Dias; Daniel Antunes Silva Pereira; Bruno Guedes Baldi; André Nathan Costa; Rodrigo Abensur Athanazio; Ronaldo Adib Kairalla; Carlos Roberto Ribeiro Carvalho
Journal:  J Bras Pneumol       Date:  2014 Jan-Feb       Impact factor: 2.624

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.